𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use

✍ Scribed by S. Xie; M. A. Furjanic; J. J. Ferrara; N. R. McAndrew; E. L. Ardino; A. Ngondara; Y. Bernstein; K. J. Thomas; E. Kim; J. M. Walker; S. Nagar; S. J. Ward; R. B. Raffa


Book ID
108849025
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
676 KB
Volume
32
Category
Article
ISSN
0269-4727

No coin nor oath required. For personal study only.